Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine

Archive ouverte

Tissot, Noémie | Brunel, Anne-Sophie | Bozon, Fabienne | Rosolen, Béatrice | Chirouze, Catherine | Bouiller, Kevin

Edité par CCSD ; Elsevier -

International audience. COVID-19 vaccination seems to be the most pertinent pharmacologic public health measure to control the pandemic. Reactogenicity symptoms were frequent in vaccine recipients mostly mild to moderate and commonly reported after the second dose. However, there is a lack of data in patients with a previous diagnosis of Covid-19.

Suggestions

Du même auteur

Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients

Archive ouverte | Lagoutte-Renosi, Jennifer | CCSD

International audience. Tenofovir disoproxil fumarate is a prodrug of tenofovir diphosphate that exposes patients to renal toxicity over the long term. Tenofovir alafenamide, a new prodrug, now makes it possible to ...

SARS‐CoV‐2 respiratory viral loads and association with clinical and biological features

Archive ouverte | Biguenet, Adrien | CCSD

International audience. To determine the distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) respiratory viral loads (VL) during the acute phase of infection and their correlation with clini...

Older adults with SARS‐CoV‐2 infection: Utility of the clinical frailty scale to predict mortality

Archive ouverte | Gilis, Marine | CCSD

International audience. The objective of this study was to identify predictive factors of mortality in older adults with coronavirus disease 2019 (COVID-19), including the level of clinical frailty by using the clin...

Chargement des enrichissements...